Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

Author affiliations

Abstract

Plant-derived edible nanoparticles (PDNPs) are nano-sized membrane vesicles released by edible plants, such as grapefruit, ginger, broccoli, and lemon. They are non-toxic, have tissue-specific targeting properties, and can be mass-produced. Thus, they have great potential for clinical applications. PDNPs offer multiple advantages over the currently available drug delivery systems, such as their relatively high internalization rate, low immunogenicity, proven stability in the gastrointestinal (GI) tract, and the ability to overcome the blood–brain barrier but not cross the placental barrier. In this review, we discuss these merits of PDNPs and analyze the current issues in PDNP research.

Graphical abstract: Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

Back to tab navigation

Publication details

The article was received on 12 Dec 2017, accepted on 29 Jan 2018 and first published on 29 Jan 2018


Article type: Review Article
DOI: 10.1039/C7TB03207B
Citation: J. Mater. Chem. B, 2018,6, 1312-1321
  •   Request permissions

    Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

    C. Yang, M. Zhang and D. Merlin, J. Mater. Chem. B, 2018, 6, 1312
    DOI: 10.1039/C7TB03207B

Search articles by author

Spotlight

Advertisements